Design and Development of a Novel Supportive Care Product for the Treatment of Sialorrhea in Parkinson’s Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|15|10|939-954

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.15, Iss.10, 2015-05, pp. : 939-954

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinson’s disease

By Jenner Peter  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 6, 2005-06 ,pp. : 729-738

Informa Healthcare

Access to resources Recommend Favorite

Caffeine as a Lead Compound for the Design of Therapeutic Agents for the Treatment of Parkinson’s Disease

By  

Current Medicinal Chemistry, Vol. 22, Iss. 8, 2015-03 ,pp. : 975-988

Bentham Science Publishers

Access to resources Recommend Favorite

Ropinirole in the treatment of Parkinson’s disease

By Zesiewicz T.A.   Hauser R.A.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 5, 1999-05 ,pp. : 697-710

Informa Healthcare

Access to resources Recommend Favorite

Non-dopaminergic drug treatment of Parkinson’s disease

By Müller T.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 4, 2001-04 ,pp. : 557-572

Informa Healthcare

Access to resources Recommend Favorite

Emerging Therapies in the Pharmacological Treatment of Parkinson’s Disease

By Korczyn A.D.   Nussbaum M.  

Drugs, Vol. 62, Iss. 5, 2002-01 ,pp. : 775-786

Adis International

Access to resources Recommend Favorite